Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities

Ellen M. Leitman, Christine D. Palmer, Søren Buus, Fabian Chen, Lynn Riddell, Stuart Sims, Paul Klenerman, Asier Sáez-Cirión, Bruce D. Walker, Paul R. Hess, Marcus Altfeld, Philippa C. Matthews, Philip J.R. Goulder*

*Corresponding author for this work
    2 Citations (Scopus)
    79 Downloads (Pure)

    Abstract

    Antigen-specific T-cells are highly variable, spanning potent antiviral efficacy and damaging auto-reactivity. In virus infections, identifying the most efficacious responses is critical to vaccine design. However, current methods depend on indirect measures or on ex vivo expanded CTL clones. We here describe a novel application of cytotoxic saporin-conjugated tetramers to kill antigen-specific T-cells without significant off-target effects. The relative efficacy of distinct antiviral CD8+ T-cell specificity can be directly assessed via antigen-specific CD8+ T-cell depletion. The utility of these reagents is demonstrated here in identifying the CD8+ T-cell specificity most effective in preventing HIV progression in HIV-infected HLA-B*27-positive immune controllers.

    Original languageEnglish
    Article numbere0184496
    JournalPLOS ONE
    Volume12
    Issue number10
    Number of pages13
    ISSN1932-6203
    DOIs
    Publication statusPublished - Oct 2017

    Fingerprint

    Dive into the research topics of 'Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities'. Together they form a unique fingerprint.

    Cite this